This South-Korea based pharma was a major leader in GLP-1 development during the 2010s, alongside Eli Lilly and Novo Nordisk, developing three different GLP-1 drugs: Efpeglenatide, a once-weekly GLP-1 agonist, Efinopegdutide, a once-weekly GLP-1/Glucagon dual agonist, and HM15211, a once-weekly GLP-1/GIP/Glucagon triple agonist
If youre starting a GLP-1 medication like semaglutide and also live with IBS, you dont need to struggle through side effects and flare-ups alone
Some peptides can also be taken orally, such as in a lozenge, spray, or capsule, which can be the most convenient option for something like intestinal or gut health benefits with BPC-157
For a deeper single-compound breakdown, see the dedicated ipamorelin peptide guide
Some people also notice temporary nausea or low energy early on, which typically improves with time and proper dose adjustments
and (iii) its ease of processing, scalability, and low production costs make it an attractive and efficient antibacterial agent 32